The vertebroplasty needles market has seen considerable growth due to a variety of factors.
• The vertebroplasty needles market has experienced rapid growth in recent years. It will increase from $1 billion in 2024 to $1.13 billion in 2025, at a CAGR of 13.0%.
Factors driving this growth include an aging population, advancements in minimally invasive techniques, heightened awareness, rising healthcare spending, the expansion of healthcare infrastructure, and increased government support and funding.
The vertebroplasty needles market is expected to maintain its strong growth trajectory in upcoming years.
• The vertebroplasty needles market is expected to grow rapidly, reaching $1.81 billion by 2029 with a CAGR of 12.7%.
Growth is attributed to the rising incidence of osteoporosis, preference for minimally invasive surgeries, and an aging population. Trends include innovations in needle design, AI and machine learning, robotics, sustainability initiatives, and telemedicine integration.
The vertebroplasty needles market is anticipated to expand due to the rising incidents of spine injuries. Spine injuries encompass any harm to the spinal cord, vertebrae, or associated tissues that induce pain, restrict mobility, or cause paralysis. A surge in spine injuries arises from aging populations, enhanced sports participation, and a high occurrence of motor vehicle incidents. Vertebroplasty needles are vital to the stabilization of spine injuries as they help in accurately injecting bone cement into the fractured vertebrae to relieve pain and recover vertebral strength. For instance, in May 2024, the Spinal Injuries Association, a US-based spinal cord injury care organization, reported roughly 4,400 new instances of spinal cord injury per year in the UK, equating to a paralysis case every two hours. This resulted in an estimated total prevalence of 105,000 spinal cord injuries in 2024. Consequently, the escalating number of spine injuries is fueling the growth of the vertebroplasty needles market.
The vertebroplasty needles market covered in this report is segmented –
1) By Type: 2.5x100, 2.5x130, 3.2x100, 3.2x130
2) By Product Type: Bone Cement Needles, Aspiration Needles
3) By Procedure Type: Percutaneous Vertebroplasty, Kyphoplasty
Subsegments
1) By 2.5x100: Single Use 2.5x100 Needle, Reusable 2.5x100 Needle
2) By 2.5x130: Single Use 2.5x130 Needle, Reusable 2.5x130 Needle
3) By 3.2x100: Single Use 3.2x100 Needle, Reusable 3.2x100 Needle
4) By 3.2x130: Single Use 3.2x130 Needle, Reusable 3.2x130 Needle
Key players in the vertebroplasty needles market are focusing their efforts on the development of innovative technologies, such as regenerative biomaterials, to enhance the efficiency of spinal treatments, improve patient results, and cut down recovery time. Regenerative biomaterials are special materials engineered to help the repair and regeneration of damaged tissues by emulating the natural extracellular structure. For example, RevBio, a clinical-stage medical device company based in the US, conducted an experiment in November 2022 to evaluate its regenerative biomaterial, Tetranite. Tetranite is a bone adhesive that can be injected and has profound effects on vertebroplasty and similar procedures. The material has the ability to unite bone fragments and fill gaps, offering instant stability through the healing course. This feature is fundamental in vertebroplasty, where the stabilization of fractured vertebrae is vital for recovery.
Major companies operating in the vertebroplasty needles market are:
• Medtronic plc
• Becton Dickinson and Company
• Stryker Corporation
• DePuy Synthes Inc
• Cook Medical LLC
• Merit Medical Systems Inc.
• Globus Medical Inc.
• Argon Medical Devices Inc.
• Amplitude Surgical SAS
• OptiMed GmbH
• Tecres S.p.A
• Zavation Medical Products LLC
• Auxein Medical Pvt Ltd
• Captiva Spine Inc.
• Laurane Medical LLC
• Osseon Technologies
• Adroit Manufacturing Co.
• BIOPSYBELL S.R.L.
• Surtech Medical Inc.
• TAEYEON Medical Co. Ltd.
• Teknimed S A S
North America was the largest region in the vertebroplasty needles market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.